DUBLIN, June 30, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "United States Anesthesia Drugs Market & Forecast" report to their offering.
United States Anesthesia Market is expected to be more than US$ 4 Billion by 2022
This growth is driven by increasing incidence of cardiovascular cases, growing old age population and rising number of urgent surgeries in United States. Private as well as public health insurers also help to boost this market as they consider anesthetic products in their reimbursement policy.
General intravenous anesthesia is the leading segments in the United States Anesthesia Market. Propofol, Benzodiazepines Class, Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate and Fentanyl are commonly used general intravenous anesthesia in the United States. Among these anesthesia, Propofol and Benzodiazepines Class are the leading anesthesia drugs which hold more than 75 percent combined market share in 2016.
In the United States anesthesia drugs market several players are selling their products. Most of the anesthesia drugs sale are in generic form as it is available in the low cost. However all major drugs manufactures such as AstraZeneca, AbbVie , Endo Healthcare etc. anesthesia products sales are turning down continuously. Only Baxter International anesthesia drugs sales are growing in the United States market.
Key Topics Covered:
1 Executive Summary
2 United States Anesthesia Drugs Market (2011 - 2022)
3 United States Anesthesia Drugs Market Share & Forecast (2011 - 2022)
4 By Type - United States Anesthesia Drugs Market (2011 - 2022)
5 By Drugs - United States General Intravenous Anesthesia Drugs Market (2011 - 2022)
6 By Drugs - United States Local Anesthesia Drugs Market (2011 - 2022)
7 Key Players Profile in United States Anesthesia Drugs Market
8 United States Anesthesia market Merger & Acquisition (M&A)
9 United States Anesthesia Reimbursement Policy - Private Health Insurance Providers
10 United States Anesthesia Reimbursement Policy - Public Health Insurance Providers
11 United States Anesthesia Drugs Market - Growth Drivers
12 United States Anesthesia Drugs Market - Challenges
- Aetna International
- Anthem Blue Cross and Blue Shield
- Baxter International Inc.
- Blue Cross and Blue Shield of Texas
- Coventry Health Care
- Endo Health Solutions Inc.
For more information about this report visit https://www.researchandmarkets.com/research/5kcwb4/united_states
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/united-states-4-bn-anesthesia-drugs-market-analysis--forecasts-2011-2022-300482542.html
SOURCE Research and Markets